GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Sensus Healthcare Inc (NAS:SRTS) » Definitions » Altman Z-Score

Sensus Healthcare (Sensus Healthcare) Altman Z-Score : 9.42 (As of May. 10, 2024)


View and export this data going back to 2016. Start your Free Trial

What is Sensus Healthcare Altman Z-Score?

The Altman Z-Score is a model designed to predict the likelihood of a company going bankrupt within the next two years. Created by American finance professor Edward Altman in 1968, the model is specifically designed for publicly traded manufacturing companies with assets greater than $1 million.

Good Sign:

Altman Z-score of 9.42 is strong.

Sensus Healthcare has a Altman Z-Score of 9.42, indicating it is in Safe Zones. This implies the Altman Z-Score is strong.

The zones of discrimination were as such:

When Altman Z-Score <= 1.8, it is in Distress Zones.
When Altman Z-Score >= 3, it is in Safe Zones.
When Altman Z-Score is between 1.8 and 3, it is in Grey Zones.

The historical rank and industry rank for Sensus Healthcare's Altman Z-Score or its related term are showing as below:

SRTS' s Altman Z-Score Range Over the Past 10 Years
Min: 1.6   Med: 6.45   Max: 12.99
Current: 9.42

During the past 11 years, Sensus Healthcare's highest Altman Z-Score was 12.99. The lowest was 1.60. And the median was 6.45.


Sensus Healthcare Altman Z-Score Historical Data

The historical data trend for Sensus Healthcare's Altman Z-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sensus Healthcare Altman Z-Score Chart

Sensus Healthcare Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Altman Z-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4.83 5.17 12.99 11.95 6.45

Sensus Healthcare Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Altman Z-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 11.95 9.56 7.02 6.05 6.45

Competitive Comparison of Sensus Healthcare's Altman Z-Score

For the Medical Devices subindustry, Sensus Healthcare's Altman Z-Score, along with its competitors' market caps and Altman Z-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sensus Healthcare's Altman Z-Score Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Sensus Healthcare's Altman Z-Score distribution charts can be found below:

* The bar in red indicates where Sensus Healthcare's Altman Z-Score falls into.



Sensus Healthcare Altman Z-Score Calculation

Altman Z-Score model is an accurate forecaster of failure up to two years prior to distress. It can be considered the assessment of the distress of industrial corporations.

Sensus Healthcare's Altman Z-Score for today is calculated with this formula:

Z=1.2*X1+1.4*X2+3.3*X3+0.6*X4+1.0*X5
=1.2*0.8437+1.4*0.1264+3.3*0.0121+0.6*12.8979+1.0*0.4544
=9.42

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency. GuruFocus does not calculate Altman Z-Score when X4 or X5 value is 0.

Trailing Twelve Months (TTM) ended in Dec. 2023:
Total Assets was $53.71 Mil.
Total Current Assets was $49.53 Mil.
Total Current Liabilities was $4.21 Mil.
Retained Earnings was $6.79 Mil.
Pre-Tax Income was 5.805 + -1.576 + -0.882 + -2.696 = $0.65 Mil.
Interest Expense was 0 + 0 + 0 + 0 = $0.00 Mil.
Revenue was 12.567 + 3.898 + 4.527 + 3.414 = $24.41 Mil.
Market Cap (Today) was $62.79 Mil.
Total Liabilities was $4.87 Mil.

* Note that for stock reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data.

X1=Working Capital/Total Assets
=(Total Current Assets - Total Current Liabilities)/Total Assets
=(49.528 - 4.212)/53.71
=0.8437

X2=Retained Earnings/Total Assets
=6.787/53.71
=0.1264

X3=Earnings Before Interest and Taxes/Total Assets
=(Pre-Tax Income - Interest Expense)/Total Assets
=(0.651 - 0)/53.71
=0.0121

X4=Market Value Equity/Book Value of Total Liabilities
=Market Cap/Total Liabilities
=62.787/4.868
=12.8979

X5=Revenue/Total Assets
=24.406/53.71
=0.4544

The zones of discrimination were as such:

Distress Zones - 1.81 < Grey Zones < 2.99 - Safe Zones

Sensus Healthcare has a Altman Z-Score of 9.42 indicating it is in Safe Zones.

Study by Altman found that companies that are in Distress Zone have more than 80% of chances of bankruptcy in two years.


Sensus Healthcare  (NAS:SRTS) Altman Z-Score Explanation

X1: The Working Capital/Total Assets (WC/TA) ratio is a measure of the net liquid assets of the firm relative to the total capitalization. Working capital is defined as the difference between current assets and current liabilities. Ordinarily, a firm experiencing consistent operating losses will have shrinking current assets in relation to total assets. Altman found this one proved to be the most valuable liquidity ratio comparing with the current ratio and the quick ratio. This is however the least significant of the five factors.

X2: Retained Earnings/Total Assets: the RE/TA ratio measures the leverage of a firm. Retained earnings is the account which reports the total amount of reinvested earnings and/or losses of a firm over its entire life. Those firms with high RE, relative to TA, have financed their assets through retention of profits and have not utilized as much debt.

X3, Earnings Before Interest and Taxes/Total Assets (EBIT/TA): This ratio is a measure of the true productivity of the firm's assets, independent of any tax or leverage factors. Since a firm's ultimate existence is based on the earning power of its assets, this ratio appears to be particularly appropriate for studies dealing with corporate failure. This ratio continually outperforms other profitability measures, including cash flow.

X4, Market Value of Equity/Book Value of Total Liabilities (MVE/TL): The measure shows how much the firm's assets can decline in value (measured by market value of equity plus debt) before the liabilities exceed the assets and the firm becomes insolvent.

X5, Revenue/Total Assets (S/TA): The capital-turnover ratio is a standard financial ratio illustrating the sales generating ability of the firm's assets.

Read more about Altman Z-Score and the original research.


Be Aware

Altman Z-Score does not apply to financial companies.


Sensus Healthcare Altman Z-Score Related Terms

Thank you for viewing the detailed overview of Sensus Healthcare's Altman Z-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


Sensus Healthcare (Sensus Healthcare) Business Description

Traded in Other Exchanges
Address
851 Broken Sound Parkway, NW, Suite 215, Boca Raton, FL, USA, 33487
Sensus Healthcare Inc is engaged in manufacturing a superficial radiotherapy system. These devices are used for treating skin cancers including basal cell and squamous cell skin cancers and other skin conditions such as keloids. Its product includes SRT-100, SRT-100 vision, and a sentinel service program. The company's revenue is generated majorly from customers in the United States.
Executives
Joseph C Sardano director, officer: Chief Executive Officer 851 BROKEN SOUND PARKWAY NW, STE. 215, BOCA RATON FL 33487
Michael Sardano officer: GENERAL COUNSEL 851 BROKEN SOUND PARKWAY NW STE. 215, BOCA RATON FL 33487
John Heinrich director 851 BROKEN SOUND PARKWAY NW, STE. 215, BOCA RATON FL 33487
Samuel O'rear director 851 BROKEN SOUND PARKWAY NW, STE. 215, BOCA RATON FL 33487
Magdalena Martinez officer: Chief Operating Officer 851 BROKEN SOUND PARKWAY NW #215, BOCA RATON FL 33487
Emiliano Sosa officer: Chief Technology Officer 851 BROKEN SOUND PARKWAY NW #215, BOCA RATON FL 33487
William H Mccall director 851 BROKEN SOUND PARKWAY NW STE. 215, BOCA RATON FL 33487
Nicolas Soro officer: Chief Operating Officer 851 BROKEN SOUND PARKWAY NW STE 215, BOCA RATON FL 33487
Javier Rampolla officer: Chief Financial Officer 851 BROKEN SOUND PARKWAY NW STE 215, BOCA RATON FL 33487
Stephen Brad Cohen officer: EXECUTIVE VICE PRESIDENT 851 BROKEN SOUND PARKWAY NW, STE. 215, BOCA RATON FL 33487
Megan Cornish director 851 BROKEN SOUND PARKWAY NW #215, BOCA RATON FL 33487
Yonatan Vainer officer: Chief Technology Officer 851 BROKEN SOUND PARKWAY NW #215, BOCA RATON FL 33487
Russ Price officer: Chief Technology Officer 851 BROKEN SOUND PARKWAY NW STE 215, BOCA RATON FL 33487
Kalman Fishman officer: CHIEF TECHNOLOGY OFFICER 851 BROKEN SOUND PARKWAY NW #215, BOCA RATON FL 33487
Richard Golin officer: EXECUTIVE VICE PRESIDENT 851 BROKEN SOUND PARKWAY NW, STE. 215, BOCA RATON FL 33487